Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Up 69.4% in August

Lonza Group Ag (OTCMKTS:LZAGY) was the target of a large increase in short interest in August. As of August 14th, there was short interest totaling 28,130 shares, an increase of 69.4% from the July 30th total of 16,610 shares. Based on an average daily trading volume, of 35,044 shares, the days-to-cover ratio is currently 0.8 days. Currently, 0.0% of the shares of the stock are short sold.

Lonza Group Trading Down 1.1%

Shares of Lonza Group stock traded down $0.79 on Monday, hitting $71.25. 26,300 shares of the company traded hands, compared to its average volume of 74,157. Lonza Group has a 52 week low of $58.53 and a 52 week high of $74.36. The business has a 50-day simple moving average of $69.86 and a 200 day simple moving average of $65.90. The company has a current ratio of 2.24, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.